[ORGANIZATION]
Nucleai
Featured in 1 tracked story · first seen
Situations
GC Cell CAR-NK therapy development
2 clusters · 4 sources · last updated
Latest: GC Cell advances GCC2005 CAR-NK therapy through AI optimization and compassionate use approval
GC Cell is progressing its GCC2005 CAR-NK cell therapy, a CD5-targeted allogeneic treatment for refractory T-cell lymphoma. The company has partnered with QuantHealth to use AI-based clinical trial simulations to optimiz